A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with ...

Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) ...

Please provide your email address to receive an email when new articles are posted on . In patients who had a heart attack but not left ventricular dysfunction, spironolactone did not improve a ...

LAS VEGAS, NV — A discharge prescription for the aldosterone blocker spironolactone in patients with a low ejection fraction who had been hospitalized for heart failure was not related to their ...

The routine administration of spironolactone to patients after a myocardial infarction (MI) did not reduce either of the coprimary outcomes in the CLEAR SYNERGY (OASIS 9) trial. However, there was a ...